Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for CGON

Stock Name	CG Oncology, Inc. Common stock
Ticker	CGON(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US1569441009

Show aggregate CGON holdings

News associated with CGON

CG Oncology (NASDAQ:CGON) Stock Price Expected to Rise, Morgan Stanley Analyst Says: CG Oncology (NASDAQ:CGON – Get Free Report) had its target price lifted by Morgan Stanley from $56.00 to $79.00 in a report issued on Wednesday, MarketBeat reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price target indicates a potential upside of 103.50% from the stock’s current price. CGON has been […] - 2025-09-19 02:36:47
CG Oncology (NASDAQ:CGON) Shares Gap Up on Insider Buying Activity: CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s share price gapped up prior to trading on Monday after an insider bought additional shares in the company. The stock had previously closed at $33.34, but opened at $35.10. CG Oncology shares last traded at $34.33, with a volume of 114,584 shares. Specifically, Director Brian Guan-Chyun Liu […] - 2025-09-17 02:12:49
CG Oncology (NASDAQ:CGON) Coverage Initiated at Jones Trading: Stock analysts at Jones Trading assumed coverage on shares of CG Oncology (NASDAQ:CGON – Get Free Report) in a research note issued to investors on Monday,Benzinga reports. The brokerage set a “buy” rating and a $50.00 price target on the stock. Jones Trading’s price objective points to a potential upside of 49.39% from the stock’s […] - 2025-09-10 02:40:50
Brokerages Set CG Oncology, Inc. (NASDAQ:CGON) Price Target at $54.30: Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy […] - 2025-09-09 02:29:01
CG Oncology (NASDAQ:CGON) Upgraded by Zacks Research to “Hold” Rating: Zacks Research upgraded shares of CG Oncology (NASDAQ:CGON – Free Report) from a strong sell rating to a hold rating in a research note published on Monday,Zacks.com reports. CGON has been the topic of a number of other research reports. Piper Sandler began coverage on CG Oncology in a report on Monday, August 18th. They […] - 2025-09-04 03:02:54
Analysts Set CG Oncology, Inc. (NASDAQ:CGON) Price Target at $55.30: Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have earned an average recommendation of “Buy” from the twelve research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating […] - 2025-08-15 02:24:52
CG Oncology, Inc. (NASDAQ:CGON) Receives $55.30 Average Target Price from Brokerages: CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) has been given an average recommendation of “Buy” by the twelve ratings firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating […] - 2025-07-21 02:30:49
Brokerages Set CG Oncology, Inc. (NASDAQ:CGON) PT at $58.67: Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have earned an average recommendation of “Buy” from the eleven research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation […] - 2025-06-26 02:23:03
CG Oncology (NASDAQ:CGON) Price Target Raised to $56.00: CG Oncology (NASDAQ:CGON – Get Free Report) had its target price hoisted by investment analysts at Morgan Stanley from $52.00 to $56.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 113.09% from the stock’s current price. […] - 2025-06-19 02:56:48
CG Oncology (NASDAQ:CGON) Trading Up 4.7% After Analyst Upgrade: CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s stock price traded up 4.7% during trading on Tuesday after Morgan Stanley raised their price target on the stock from $52.00 to $56.00. Morgan Stanley currently has an overweight rating on the stock. CG Oncology traded as high as $26.31 and last traded at $26.65. 213,112 shares […] - 2025-06-19 02:13:09
CG Oncology, Inc. (NASDAQ:CGON) Position Decreased by Nuveen Asset Management LLC: Nuveen Asset Management LLC decreased its holdings in shares of CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 27.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 111,716 shares of the company’s stock after selling 41,918 shares during the period. […] - 2025-06-02 04:58:49
ProShare Advisors LLC Acquires 7,599 Shares of CG Oncology, Inc. (NASDAQ:CGON): ProShare Advisors LLC boosted its holdings in CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 84.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 16,561 shares of the company’s stock after acquiring an additional 7,599 shares during the period. ProShare Advisors […] - 2025-05-27 06:37:07
Morgan Stanley Has Lowered Expectations for CG Oncology (NASDAQ:CGON) Stock Price: CG Oncology (NASDAQ:CGON – Get Free Report) had its price objective dropped by investment analysts at Morgan Stanley from $55.00 to $52.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price target indicates a potential upside of 95.78% from the stock’s current price. A […] - 2025-05-21 02:56:59
CG Oncology (NASDAQ:CGON) Shares Gap Down After Earnings Miss: CG Oncology, Inc. (NASDAQ:CGON – Get Free Report)’s share price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously closed at $25.16, but opened at $24.21. CG Oncology shares last traded at $24.95, with a volume of 42,738 shares. The company reported ($0.45) earnings per share […] - 2025-05-15 02:18:49
CG Oncology, Inc. (NASDAQ:CGON) Receives $57.70 Consensus Price Target from Brokerages: Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have earned a consensus recommendation of “Buy” from the twelve analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, ten have issued a buy recommendation and one has issued a strong buy recommendation on the […] - 2025-05-07 02:19:09
CG Oncology, Inc. (NASDAQ:CGON) Shares Acquired by Wells Fargo & Company MN: Wells Fargo & Company MN grew its stake in CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 45.3% during the fourth quarter, HoldingsChannel reports. The firm owned 28,234 shares of the company’s stock after purchasing an additional 8,803 shares during the quarter. Wells Fargo & Company MN’s holdings in CG Oncology were worth $810,000 as […] - 2025-05-01 05:08:57
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 09:31:47
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 08:55:47
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 08:28:41
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 05:42:14
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 03:41:45
Stocks Settle Mixed Awaiting Trade News and Big Tech Earnings: The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.03%. June E-mini S&P futures (ESM25 ) are up +0.03%, and June E-mini Nasdaq futures... - 2025-04-29 01:15:49
Stocks Mixed on Trade News and Chip Stock Weakness: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. June E-mini S&P futures (ESM25 ) are up +0.02%, and June E-mini Nasdaq futures... - 2025-04-28 19:59:34
Stocks Climb on Hopes of US Trade Deals: The S&P 500 Index ($SPX ) (SPY ) today is up +0.44%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. June E-mini S&P futures (ESM25 ) are up +0.41%, and June E-mini Nasdaq futures... - 2025-04-28 17:47:00
Stocks Mixed on Trade News and Chip Stock Weakness: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. June E-mini S&P futures (ESM25 ) are up +0.02%, and June E-mini Nasdaq futures... - 2025-04-28 14:54:49
Stocks Mixed on Trade News and Chip Stock Weakness: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. June E-mini S&P futures (ESM25 ) are up +0.02%, and June E-mini Nasdaq futures... - 2025-04-28 14:42:47
Stocks Mixed on Trade News and Chip Stock Weakness: The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.29%. June E-mini S&P futures (ESM25 ) are up +0.02%, and June E-mini Nasdaq futures... - 2025-04-28 14:28:17
Stocks Climb on Hopes of US Trade Deals: The S&P 500 Index ($SPX ) (SPY ) today is up +0.44%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. June E-mini S&P futures (ESM25 ) are up +0.41%, and June E-mini Nasdaq futures... - 2025-04-28 14:11:20
Legal & General Group Plc Acquires 2,793 Shares of CG Oncology, Inc. (NASDAQ:CGON): Legal & General Group Plc raised its position in CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 10.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 29,262 shares of the company’s stock after acquiring an additional 2,793 shares during the period. Legal & General Group Plc’s holdings in CG Oncology were worth $839,000 […] - 2025-04-28 05:02:55
Vanguard Group Inc. Boosts Stock Position in CG Oncology, Inc. (NASDAQ:CGON): Vanguard Group Inc. lifted its stake in CG Oncology, Inc. (NASDAQ:CGON – Free Report) by 15.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 5,861,082 shares of the company’s stock after purchasing an additional 779,730 shares during the period. Vanguard Group Inc. owned approximately 0.08% of CG Oncology worth $168,096,000 as of its […] - 2025-04-07 04:41:00

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) CGON holdings

Date	Number of CGON Shares Held	Base Market Value of CGON Shares	Local Market Value of CGON Shares	Change in CGON Shares Held	Change in CGON Base Value	Current Price per CGON Share Held	Previous Price per CGON Share Held
2026-01-15 (Thursday)	55,041	USD 2,921,026	USD 2,921,026	250	USD -120,422	USD 53.07	USD 55.51
2026-01-14 (Wednesday)	54,791	USD 3,041,448	USD 3,041,448	250	USD 173,682	USD 55.51	USD 52.58
2026-01-13 (Tuesday)	54,541	USD 2,867,766	USD 2,867,766	0	USD -62,177	USD 52.58	USD 53.72
2026-01-12 (Monday)	54,541	USD 2,929,943	USD 2,929,943	625	USD 7,696	USD 53.72	USD 54.2
2026-01-09 (Friday)	53,916	USD 2,922,247	USD 2,922,247	0	USD 661,549	USD 54.2	USD 41.93
2026-01-08 (Thursday)	53,916	USD 2,260,698	USD 2,260,698	0	USD -28,036	USD 41.93	USD 42.45
2026-01-07 (Wednesday)	53,916	USD 2,288,734	USD 2,288,734	250	USD 122,238	USD 42.45	USD 40.37
2026-01-06 (Tuesday)	53,666	USD 2,166,496	USD 2,166,496	0	USD 17,709	USD 40.37	USD 40.04
2026-01-05 (Monday)	53,666	USD 2,148,787	USD 2,148,787	0	USD -93,915	USD 40.04	USD 41.79
2026-01-02 (Friday)	53,666	USD 2,242,702	USD 2,242,702	125	USD 19,680	USD 41.79	USD 41.52
2025-12-31 (Wednesday)	53,541	USD 2,223,022	USD 2,223,022	0	USD 72,280	USD 41.52	USD 40.17

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CGON by Blackrock for IE00BDZVHG35

Show aggregate share trades of CGON

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 250 56.350 52.600 52.975 USD 13,244 31.82
2026-01-14 BUY 250 56.430 51.580 52.065 USD 13,016 31.70
2026-01-12 BUY 625 56.800 52.000 52.480 USD 32,800 31.48
2026-01-07 BUY 250 43.430 40.240 40.559 USD 10,140 31.26
2026-01-02 BUY 125 42.040 40.801 40.925 USD 5,116 31.11
2025-12-30 BUY 125 40.340 39.550 39.629 USD 4,954 31.01
2025-12-23 SELL -1,500 40.850 39.720 39.833 USD -59,750 30.81 Loss of -13,532 on sale
2025-12-19 SELL -1,207 39.800 37.730 37.937 USD -45,790 30.72 Loss of -8,715 on sale
2025-12-17 SELL -640 38.290 37.010 37.138 USD -23,768 30.64 Loss of -4,159 on sale
2025-12-16 SELL -128 40.115 37.740 37.978 USD -4,861 30.60 Loss of -944 on sale
2025-12-15 BUY 256 41.640 39.500 39.714 USD 10,167 30.55
2025-12-11 BUY 258 42.750 41.300 41.445 USD 10,693 30.43
2025-12-04 BUY 2,560 45.120 41.550 41.907 USD 107,282 30.07
2025-12-02 BUY 1,920 43.970 41.350 41.612 USD 79,895 29.93
2025-11-28 BUY 128 45.935 44.265 44.432 USD 5,687 29.76
2025-11-26 BUY 384 45.775 44.270 44.421 USD 17,057 29.58
2025-11-26 BUY 384 45.775 44.270 44.421 USD 17,057 29.58
2025-11-25 BUY 640 45.560 43.045 43.296 USD 27,710 29.48
2025-11-24 BUY 128 44.500 42.560 42.754 USD 5,473 29.39
2025-11-20 SELL -512 44.560 40.640 41.032 USD -21,008 29.24 Loss of -6,036 on sale
2025-11-19 BUY 128 43.790 41.980 42.161 USD 5,397 29.16
2025-11-18 BUY 768 43.730 39.340 39.779 USD 30,550 29.08
2025-11-17 BUY 256 42.900 39.205 39.575 USD 10,131 29.00
2025-11-14 BUY 128 41.730 37.285 37.729 USD 4,829 28.92
2025-11-12 BUY 128 39.950 37.930 38.132 USD 4,881 28.80
2025-11-10 BUY 127 41.080 39.880 40.000 USD 5,080 28.66
2025-11-06 BUY 127 40.040 38.055 38.254 USD 4,858 28.51
2025-11-04 BUY 128 41.400 38.960 39.204 USD 5,018 28.38
2025-10-30 BUY 640 43.580 42.060 42.212 USD 27,016 28.09
2025-10-29 BUY 256 42.980 43.725 43.650 USD 11,175 27.99
2025-10-22 SELL -512 41.910 42.800 42.711 USD -21,868 27.45 Loss of -7,811 on sale
2025-10-20 BUY 256 43.590 43.720 43.707 USD 11,189 27.23
2025-10-17 BUY 639 41.460 42.150 42.081 USD 26,890 27.12
2025-10-15 BUY 1,016 43.050 45.090 44.886 USD 45,604 27.01
2025-10-03 BUY 875 39.820 40.265 40.220 USD 35,193 26.79
2025-10-02 BUY 125 39.855 40.360 40.310 USD 5,039 26.70
2025-09-30 BUY 250 40.280 40.530 40.505 USD 10,126 26.50
2025-09-26 BUY 252 37.540 38.050 37.999 USD 9,576 26.32
2025-09-25 BUY 252 36.480 36.820 36.786 USD 9,270 26.24
2025-09-18 BUY 131 38.820 39.150 39.117 USD 5,124 26.14
2025-09-17 BUY 396 37.720 38.910 38.791 USD 15,361 26.05
2025-09-11 SELL -131 33.160 34.630 34.483 USD -4,517 25.91 Loss of -1,123 on sale
2025-09-10 BUY 262 33.630 34.735 34.625 USD 9,072 25.85
2025-07-17 SELL -262 28.460 28.550 28.541 USD -7,478 25.75 Loss of -732 on sale
2025-07-11 SELL -1,048 26.720 27.090 27.053 USD -28,352 25.74 Loss of -1,373 on sale
2025-07-02 BUY 7,205 26.680 27.275 27.215 USD 196,088 25.70
2025-06-25 BUY 262 26.060 26.560 26.510 USD 6,946 25.69
2025-06-20 BUY 1,009 25.550 26.460 26.369 USD 26,606 25.69
2025-06-11 BUY 256 26.180 27.950 27.773 USD 7,110 25.66
2025-06-10 BUY 256 27.480 28.000 27.948 USD 7,155 25.64
2025-06-04 SELL -128 26.580 26.980 26.940 USD -3,448 25.59 Loss of -173 on sale
2025-04-23 BUY 128 20.730 21.595 21.508 USD 2,753 25.75
2025-04-10 SELL -1,024 17.630 18.080 18.035 USD -18,468 26.71 Profit of 8,888 on sale
2025-04-08 SELL -128 15.590 19.280 18.911 USD -2,421 27.10 Profit of 1,048 on sale
2025-04-07 SELL -128 16.920 17.960 17.856 USD -2,286 27.30 Profit of 1,209 on sale
2025-04-04 SELL -640 17.200 18.550 18.415 USD -11,786 27.50 Profit of 5,815 on sale
2025-04-01 BUY 1,453 22.050 24.351 24.121 USD 35,048 27.72
2025-03-31 SELL -375 24.490 26.820 26.587 USD -9,970 27.79 Profit of 452 on sale
2025-03-21 BUY 5,627 27.050 28.575 28.423 USD 159,933 27.88
2025-03-14 SELL -1,712 27.800 28.650 28.565 USD -48,903 27.90 Loss of -1,131 on sale
2025-03-07 SELL -214 26.720 27.830 27.719 USD -5,932 28.15 Profit of 93 on sale
2025-03-04 SELL -107 24.800 25.570 25.493 USD -2,728 28.36 Profit of 307 on sale
2025-02-25 BUY 214 25.000 27.790 27.511 USD 5,887 29.06
2025-02-19 SELL -106 27.520 27.710 27.691 USD -2,935 29.37 Profit of 178 on sale
2025-02-13 BUY 318 28.500 28.870 28.833 USD 9,169 29.68
2025-02-12 BUY 106 28.000 28.195 28.175 USD 2,987 29.80
2025-02-11 BUY 424 27.520 28.250 28.177 USD 11,947 29.97
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	250	56.350	52.600	52.975	USD 13,244	31.82
2026-01-14	BUY	250	56.430	51.580	52.065	USD 13,016	31.70
2026-01-12	BUY	625	56.800	52.000	52.480	USD 32,800	31.48
2026-01-07	BUY	250	43.430	40.240	40.559	USD 10,140	31.26
2026-01-02	BUY	125	42.040	40.801	40.925	USD 5,116	31.11
2025-12-30	BUY	125	40.340	39.550	39.629	USD 4,954	31.01
2025-12-23	SELL	-1,500	40.850	39.720	39.833	USD -59,750	30.81 Loss of -13,532 on sale
2025-12-19	SELL	-1,207	39.800	37.730	37.937	USD -45,790	30.72 Loss of -8,715 on sale
2025-12-17	SELL	-640	38.290	37.010	37.138	USD -23,768	30.64 Loss of -4,159 on sale
2025-12-16	SELL	-128	40.115	37.740	37.978	USD -4,861	30.60 Loss of -944 on sale
2025-12-15	BUY	256	41.640	39.500	39.714	USD 10,167	30.55
2025-12-11	BUY	258	42.750	41.300	41.445	USD 10,693	30.43
2025-12-04	BUY	2,560	45.120	41.550	41.907	USD 107,282	30.07
2025-12-02	BUY	1,920	43.970	41.350	41.612	USD 79,895	29.93
2025-11-28	BUY	128	45.935	44.265	44.432	USD 5,687	29.76
2025-11-26	BUY	384	45.775	44.270	44.421	USD 17,057	29.58
2025-11-26	BUY	384	45.775	44.270	44.421	USD 17,057	29.58
2025-11-25	BUY	640	45.560	43.045	43.296	USD 27,710	29.48
2025-11-24	BUY	128	44.500	42.560	42.754	USD 5,473	29.39
2025-11-20	SELL	-512	44.560	40.640	41.032	USD -21,008	29.24 Loss of -6,036 on sale
2025-11-19	BUY	128	43.790	41.980	42.161	USD 5,397	29.16
2025-11-18	BUY	768	43.730	39.340	39.779	USD 30,550	29.08
2025-11-17	BUY	256	42.900	39.205	39.575	USD 10,131	29.00
2025-11-14	BUY	128	41.730	37.285	37.729	USD 4,829	28.92
2025-11-12	BUY	128	39.950	37.930	38.132	USD 4,881	28.80
2025-11-10	BUY	127	41.080	39.880	40.000	USD 5,080	28.66
2025-11-06	BUY	127	40.040	38.055	38.254	USD 4,858	28.51
2025-11-04	BUY	128	41.400	38.960	39.204	USD 5,018	28.38
2025-10-30	BUY	640	43.580	42.060	42.212	USD 27,016	28.09
2025-10-29	BUY	256	42.980	43.725	43.650	USD 11,175	27.99
2025-10-22	SELL	-512	41.910	42.800	42.711	USD -21,868	27.45 Loss of -7,811 on sale
2025-10-20	BUY	256	43.590	43.720	43.707	USD 11,189	27.23
2025-10-17	BUY	639	41.460	42.150	42.081	USD 26,890	27.12
2025-10-15	BUY	1,016	43.050	45.090	44.886	USD 45,604	27.01
2025-10-03	BUY	875	39.820	40.265	40.220	USD 35,193	26.79
2025-10-02	BUY	125	39.855	40.360	40.310	USD 5,039	26.70
2025-09-30	BUY	250	40.280	40.530	40.505	USD 10,126	26.50
2025-09-26	BUY	252	37.540	38.050	37.999	USD 9,576	26.32
2025-09-25	BUY	252	36.480	36.820	36.786	USD 9,270	26.24
2025-09-18	BUY	131	38.820	39.150	39.117	USD 5,124	26.14
2025-09-17	BUY	396	37.720	38.910	38.791	USD 15,361	26.05
2025-09-11	SELL	-131	33.160	34.630	34.483	USD -4,517	25.91 Loss of -1,123 on sale
2025-09-10	BUY	262	33.630	34.735	34.625	USD 9,072	25.85
2025-07-17	SELL	-262	28.460	28.550	28.541	USD -7,478	25.75 Loss of -732 on sale
2025-07-11	SELL	-1,048	26.720	27.090	27.053	USD -28,352	25.74 Loss of -1,373 on sale
2025-07-02	BUY	7,205	26.680	27.275	27.215	USD 196,088	25.70
2025-06-25	BUY	262	26.060	26.560	26.510	USD 6,946	25.69
2025-06-20	BUY	1,009	25.550	26.460	26.369	USD 26,606	25.69
2025-06-11	BUY	256	26.180	27.950	27.773	USD 7,110	25.66
2025-06-10	BUY	256	27.480	28.000	27.948	USD 7,155	25.64
2025-06-04	SELL	-128	26.580	26.980	26.940	USD -3,448	25.59 Loss of -173 on sale
2025-04-23	BUY	128	20.730	21.595	21.508	USD 2,753	25.75
2025-04-10	SELL	-1,024	17.630	18.080	18.035	USD -18,468	26.71 Profit of 8,888 on sale
2025-04-08	SELL	-128	15.590	19.280	18.911	USD -2,421	27.10 Profit of 1,048 on sale
2025-04-07	SELL	-128	16.920	17.960	17.856	USD -2,286	27.30 Profit of 1,209 on sale
2025-04-04	SELL	-640	17.200	18.550	18.415	USD -11,786	27.50 Profit of 5,815 on sale
2025-04-01	BUY	1,453	22.050	24.351	24.121	USD 35,048	27.72
2025-03-31	SELL	-375	24.490	26.820	26.587	USD -9,970	27.79 Profit of 452 on sale
2025-03-21	BUY	5,627	27.050	28.575	28.423	USD 159,933	27.88
2025-03-14	SELL	-1,712	27.800	28.650	28.565	USD -48,903	27.90 Loss of -1,131 on sale
2025-03-07	SELL	-214	26.720	27.830	27.719	USD -5,932	28.15 Profit of 93 on sale
2025-03-04	SELL	-107	24.800	25.570	25.493	USD -2,728	28.36 Profit of 307 on sale
2025-02-25	BUY	214	25.000	27.790	27.511	USD 5,887	29.06
2025-02-19	SELL	-106	27.520	27.710	27.691	USD -2,935	29.37 Profit of 178 on sale
2025-02-13	BUY	318	28.500	28.870	28.833	USD 9,169	29.68
2025-02-12	BUY	106	28.000	28.195	28.175	USD 2,987	29.80
2025-02-11	BUY	424	27.520	28.250	28.177	USD 11,947	29.97

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CGON

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	169,299	0	327,645	51.7%
2025-09-18	236,356	1	487,925	48.4%
2025-09-17	662,335	697	834,027	79.4%
2025-09-16	514,864	206	623,703	82.5%
2025-09-15	340,321	4	406,069	83.8%
2025-09-12	500,320	357	873,077	57.3%
2025-09-11	430,015	0	2,289,239	18.8%
2025-09-10	310,123	0	542,845	57.1%
2025-09-09	156,331	1,551	230,380	67.9%
2025-09-08	326,419	33	606,906	53.8%
2025-09-05	527,915	1	771,461	68.4%
2025-09-04	394,926	2,396	509,737	77.5%
2025-09-03	262,983	40,888	304,216	86.4%
2025-09-02	101,295	2,788	137,556	73.6%
2025-08-29	86,952	0	109,930	79.1%
2025-08-28	73,639	0	128,912	57.1%
2025-08-27	101,665	0	148,518	68.5%
2025-08-26	296,523	0	359,851	82.4%
2025-08-25	77,495	1,886	108,120	71.7%
2025-08-22	127,950	8,215	185,362	69.0%
2025-08-21	79,914	100	101,370	78.8%
2025-08-20	53,153	0	70,204	75.7%
2025-08-19	74,355	0	82,454	90.2%
2025-08-18	98,535	0	137,790	71.5%
2025-08-15	42,984	0	78,013	55.1%
2025-08-14	82,712	14,532	118,784	69.6%
2025-08-13	86,520	0	269,029	32.2%
2025-08-12	60,067	0	149,062	40.3%
2025-08-11	104,944	0	196,257	53.5%
2025-08-08	83,269	0	159,665	52.2%
2025-08-07	119,711	4	216,070	55.4%
2025-08-06	152,591	65	193,984	78.7%
2025-08-05	286,205	0	306,548	93.4%
2025-08-04	167,042	0	257,256	64.9%
2025-08-01	173,131	0	303,881	57.0%
2025-07-31	171,268	0	326,208	52.5%
2025-07-30	270,432	0	542,556	49.8%
2025-07-29	429,211	0	558,185	76.9%
2025-07-28	207,928	8	536,417	38.8%
2025-07-25	296,220	0	574,019	51.6%
2025-07-24	160,843	222	307,800	52.3%
2025-07-23	231,890	0	561,911	41.3%
2025-07-22	284,980	0	822,188	34.7%
2025-07-21	360,921	100	390,828	92.3%
2025-07-18	541,950	398	662,245	81.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE